Friday, August 19, 2022 9:12:32 AM
Recent PSTV News
- Plus Therapeutics Showcases Leptomeningeal Metastases Programs at 2024 SNO/ASCO Conference • GlobeNewswire Inc. • 07/25/2024 11:30:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 07/12/2024 08:40:13 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 07/10/2024 04:12:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 07/10/2024 11:00:19 AM
- Plus Therapeutics to Present at the Gordon Research Conference Radionuclide Theranostics for the Management of Cancer • GlobeNewswire Inc. • 07/02/2024 11:30:00 AM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 06/07/2024 09:02:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 08:02:15 PM
- Plus Therapeutics Expands Management Team and Reports $3.3M Advance Payment from CPRIT • GlobeNewswire Inc. • 06/07/2024 11:30:00 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 06/05/2024 11:26:01 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:16:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 11:00:11 AM
- Plus Therapeutics Announces New Employment Inducement Grants • GlobeNewswire Inc. • 05/17/2024 09:00:00 PM
- Plus Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights • GlobeNewswire Inc. • 05/15/2024 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 08:01:57 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 08:00:50 PM
- Plus Therapeutics to Announce First Quarter Financial Results and Host Conference Call on May 15, 2024 • GlobeNewswire Inc. • 05/13/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/10/2024 11:30:19 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/10/2024 11:30:17 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/10/2024 11:30:14 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/10/2024 11:30:11 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/10/2024 11:30:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/10/2024 11:30:06 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 09:20:34 PM
- Plus Therapeutics Provides Highlights Regarding Leptomeningeal Metastases Acquisition and Topline Clinical Trial Data on the FORESEE Trial • GlobeNewswire Inc. • 05/09/2024 03:29:23 PM
- Plus Therapeutics to Host Investor Call to Discuss Leptomeningeal Cancer Related Acquisition and Topline Clinical Trial Data from the FORESEE Trial • GlobeNewswire Inc. • 05/08/2024 09:35:00 PM
FEATURED Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA • Jul 29, 2024 9:07 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM
BNCM AND DELEX UNVEIL POST-MERGER MANAGEMENT PLANS • BNCM • Jul 29, 2024 9:00 AM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM